BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15647017)

  • 1. Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature.
    Ziman A; Mitri M; Klapper E; Pepkowitz SH; Goldfinger D
    Transfusion; 2005 Jan; 45(1):41-9. PubMed ID: 15647017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.
    Hong H; Xiao W; Stempak LM; Sandhaus LM; Maitta RW
    Transfusion; 2015 Apr; 55(4):756-65. PubMed ID: 25370931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
    Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
    Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of 50% albumin/plasma replacement fluid in therapeutic plasma exchange for thrombotic thrombocytopenic purpura.
    O'Brien KL; Price TH; Howell C; Delaney M
    J Clin Apher; 2013 Dec; 28(6):416-21. PubMed ID: 23857424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine.
    Böhm M; Betz C; Miesbach W; Krause M; von Auer C; Geiger H; Scharrer I
    Br J Haematol; 2005 Jun; 129(5):644-52. PubMed ID: 15916687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP.
    Bobbio-Pallavicini E; Porta C; Centurioni R; Gugliotta L; Vianelli N; Tacconi F; Billio A; Ascari E
    Eur J Haematol; 1994 Apr; 52(4):222-6. PubMed ID: 8005232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura after prophylactic cefuroxime axetil administered in relation to a liposuction procedure.
    Eskazan AE; Salihoglu A; Gulturk E; Ongoren S; Soysal T
    Aesthetic Plast Surg; 2012 Apr; 36(2):464-7. PubMed ID: 21853406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitor.
    Pandey S; Nakagawa M; Rosenbaum ER; Arnaoutakis K; Hutchins LF; Makhoul I; Milojkovic N; Cottler-Fox M
    J Clin Apher; 2015 Feb; 30(1):50-4. PubMed ID: 25042026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
    Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vincristine played a pivotal role in hematological remission of thrombotic thrombocytopenic purpura (T.T.P.)].
    Imai N; Miyazaki M; Okada M; Urase Y; Ohhata S; Matsumoto M; Hattori K; Kubori S
    Rinsho Ketsueki; 1992 Nov; 33(11):1714-9. PubMed ID: 1469789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
    Connell NT; Cheves T; Sweeney JD
    Transfusion; 2016 Feb; 56(2):354-9. PubMed ID: 26456149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura.
    Moore JC; Arnold DM; Leber BF; Clare R; Molnar GJ; Kelton JG
    Vox Sang; 2007 Aug; 93(2):173-5. PubMed ID: 17683362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutical plasma exchange for thrombotic thrombocytopenic purpura in the emergency department: A single center experience.
    Li XM; Mo XY; Huang GQ; Zhang FJ
    Am J Emerg Med; 2021 Aug; 46():556-559. PubMed ID: 33214018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.
    Peedin AR; Park YA; Mazepa MA; Rollins-Raval MA; Brecher ME; Raval JS
    Ther Apher Dial; 2018 Dec; 22(6):662-665. PubMed ID: 30178615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura.
    Liu C; Kallogjeri D; Dynis M; Grossman BJ
    Transfusion; 2013 May; 53(5):1096-107. PubMed ID: 22905833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice daily plasma exchange in refractory thrombotic thrombocytopenic purpura.
    Kahwash E; Lockwood WB
    Ther Apher Dial; 2004 Jun; 8(3):254-7. PubMed ID: 15154880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
    Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
    Coppo P; Froissart A;
    Hematology Am Soc Hematol Educ Program; 2015; 2015():637-43. PubMed ID: 26637782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
    Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
    J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.